AI Engines For more Details: Perplexity Kagi Labs You
Alpha-Adrenergic Blockade: Phenoxybenzamine is a non-selective alpha-adrenergic antagonist, meaning it blocks the action of adrenaline and noradrenaline on both alpha-1 and alpha-2 adrenergic receptors. By blocking these receptors, it causes vasodilation (widening of blood vessels) and reduces the effects of sympathetic nervous system activation, leading to a decrease in blood pressure.
Treatment of Pheochromocytoma: Phenoxybenzamine is particularly effective in the management of pheochromocytoma, a rare tumor of the adrenal gland that produces excess catecholamines (epinephrine and norepinephrine). By blocking the alpha-adrenergic receptors, phenoxybenzamine helps control hypertension and reduces the risk of hypertensive crisis associated with pheochromocytoma.
Orthostatic Hypotension: One of the side effects of phenoxybenzamine is orthostatic hypotension, which is a sudden drop in blood pressure upon standing up from a lying or sitting position. This can lead to dizziness, lightheadedness, or even fainting. Patients should be advised to change positions slowly to minimize this risk.
Reflex Tachycardia: Phenoxybenzamine-induced vasodilation can trigger reflex tachycardia (rapid heart rate) as the body attempts to compensate for the decrease in blood pressure. This effect may be more pronounced in some individuals, particularly those with pre-existing cardiovascular conditions.
Nasal Congestion: Phenoxybenzamine can cause nasal congestion as a result of its alpha-blocking effects on blood vessels in the nasal mucosa. This side effect may be bothersome for some patients but is generally mild and transient.
Gastrointestinal Effects: Gastrointestinal side effects such as nausea, vomiting, and diarrhea may occur with phenoxybenzamine use. These effects are usually mild and may improve with continued use or dose adjustment.
Urinary Retention: Phenoxybenzamine may impair bladder function and lead to urinary retention, particularly in men with prostatic hypertrophy. Patients should be monitored for urinary symptoms and advised to seek medical attention if they experience difficulty urinating.
Ocular Effects: Phenoxybenzamine can cause miosis (pupil constriction) and blurred vision due to its effects on alpha-adrenergic receptors in the eye. Patients should use caution when driving or operating machinery, especially in low-light conditions.
Edema: Peripheral edema (swelling of the extremities) may occur as a result of fluid redistribution caused by phenoxybenzamine-induced vasodilation. Patients with heart failure or renal impairment may be at increased risk of developing edema.
Hypotension During Surgery: Phenoxybenzamine is sometimes used preoperatively to control blood pressure during surgical removal of pheochromocytoma. Careful monitoring of blood pressure and hemodynamic parameters is essential during surgery to prevent hypotension and maintain adequate perfusion to vital organs.
Interactions: Phenoxybenzamine may interact with other medications, particularly other antihypertensive drugs, leading to additive effects on blood pressure. Patients should inform their healthcare provider about all medications they are taking, including prescription, over-the-counter, and herbal supplements.
Rank | Probiotic | Impact |
---|---|---|
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Blautia hansenii | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Escherichia coli | Reduces |
species | Lactococcus cremoris | Reduces |
species | Lactococcus lactis | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Blautia | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Lachnoclostridium | genus | Decreases |
0 | 1 | Anaerostipes | genus | Decreases |
0 | 1 | Veillonella | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
1 | 0 | Blautia obeum | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Roseburia intestinalis | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Parabacteroides merdae | species | Decreases |
0 | 1 | Blautia argi | species | Decreases |
0 | 1 | Bacteroides humanifaecis | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Bacteroides sp. A1C1 | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Bacteroides sp. CACC 737 | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Dorea formicigenerans | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
1 | 0 | Veillonella parvula | species | Decreases |
1 | 0 | Bacteroides thetaiotaomicron | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Coprococcus comes | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | Ruthenibacterium lactatiformans | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Eubacterium callanderi | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Clostridium sp. C1 | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
1 | 0 | Lacrimispora saccharolytica | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 171 | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Faecalibaculum rodentium | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Escherichia fergusonii | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | [Eubacterium] hominis | species | Decreases |
0 | 1 | Segatella bryantii | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Actinomyces sp. oral taxon 169 | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Blautia parvula | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Eubacterium maltosivorans | species | Decreases |
0 | 1 | Romboutsia ilealis | species | Decreases |
0 | 1 | Treponema denticola | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Bacteroides sp. HF-162 | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Enterococcus cecorum | species | Decreases |
0 | 1 | Emergencia timonensis | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Phascolarctobacterium succinatutens | species | Decreases |
0 | 1 | [Clostridium] scindens | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Thomasclavelia ramosa | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Butyrivibrio fibrisolvens | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Lactococcus lactis | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Roseburia hominis | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Blautia hansenii | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Blautia pseudococcoides | species | Decreases |
0 | 1 | Shigella boydii | species | Decreases |
0 | 1 | Gordonibacter urolithinfaciens | species | Decreases |
0 | 1 | Leyella stercorea | species | Decreases |
0 | 1 | Rothia dentocariosa | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Blautia producta | species | Decreases |
0 | 1 | Butyricicoccus sp. GAM44 | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Ruminococcus bovis | species | Decreases |
0 | 1 | Enterocloster bolteae | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | Anaerostipes caccae | species | Decreases |
0 | 1 | Anaerotruncus colihominis | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Adlercreutzia hattorii | species | Decreases |
0 | 1 | Streptococcus mutans | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | Romboutsia sp. 13368 | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Streptococcus sanguinis | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Turicibacter bilis | species | Decreases |
0 | 1 | Amedibacterium intestinale | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Arabiibacter massiliensis | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.2 | 0.2 | |
ADHD | 1 | 0.3 | 2.33 |
Age-Related Macular Degeneration and Glaucoma | 0.4 | 0.1 | 3 |
Allergic Rhinitis (Hay Fever) | 1.7 | 0.4 | 3.25 |
Allergies | 2.8 | 0.5 | 4.6 |
Allergy to milk products | 0.5 | 0.7 | -0.4 |
Alopecia (Hair Loss) | 0.5 | 0.1 | 4 |
Alzheimer's disease | 2.2 | 3.8 | -0.73 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 1 | 0.4 | 1.5 |
Ankylosing spondylitis | 1.5 | 0.9 | 0.67 |
Anorexia Nervosa | 0.5 | 1.8 | -2.6 |
Antiphospholipid syndrome (APS) | 1 | 1 | |
Asthma | 1.8 | 0.5 | 2.6 |
Atherosclerosis | 1.3 | 0.7 | 0.86 |
Atrial fibrillation | 1.8 | 1.2 | 0.5 |
Autism | 4 | 3.3 | 0.21 |
Autoimmune Disease | 0.2 | 0.2 | 0 |
Barrett esophagus cancer | 0.1 | 0.1 | |
benign prostatic hyperplasia | 0.2 | 0.2 | 0 |
Biofilm | 1.2 | 1.2 | |
Bipolar Disorder | 0.6 | 0.3 | 1 |
Brain Trauma | 0.1 | 0.4 | -3 |
Breast Cancer | 0.4 | 0.4 | |
Cancer (General) | 0.1 | 0.1 | 0 |
Carcinoma | 1 | 0.7 | 0.43 |
Celiac Disease | 1.8 | 1 | 0.8 |
Cerebral Palsy | 0.3 | 0.9 | -2 |
Chronic Fatigue Syndrome | 2.7 | 2.5 | 0.08 |
Chronic Kidney Disease | 1.9 | 1.7 | 0.12 |
Chronic Lyme | 0.4 | -0.4 | |
Chronic Obstructive Pulmonary Disease (COPD) | 0.4 | 0.5 | -0.25 |
Chronic Urticaria (Hives) | 0.5 | 0.9 | -0.8 |
Coagulation / Micro clot triggering bacteria | 0.6 | 0.9 | -0.5 |
Cognitive Function | 0.3 | 0.2 | 0.5 |
Colorectal Cancer | 2.7 | 1.2 | 1.25 |
Constipation | 0.4 | 0.6 | -0.5 |
Coronary artery disease | 1.6 | 2.2 | -0.38 |
COVID-19 | 3.5 | 5.7 | -0.63 |
Crohn's Disease | 3.5 | 2.4 | 0.46 |
Cushing's Syndrome (hypercortisolism) | 0.2 | -0.2 | |
cystic fibrosis | 0.5 | 0.8 | -0.6 |
d-lactic acidosis (one form of brain fog) | 0.4 | 0.4 | |
deep vein thrombosis | 1.3 | 0.6 | 1.17 |
Denture Wearers Oral Shifts | 0.4 | 0.4 | |
Depression | 3.1 | 3.2 | -0.03 |
Dermatomyositis | 0.1 | 0.1 | |
Eczema | 0.8 | 0.6 | 0.33 |
Endometriosis | 1.2 | 0.7 | 0.71 |
Eosinophilic Esophagitis | 0.1 | -0.1 | |
Epilepsy | 1.9 | 1 | 0.9 |
erectile dysfunction | 0.5 | 0.5 | |
Fibromyalgia | 1.5 | 1.2 | 0.25 |
Functional constipation / chronic idiopathic constipation | 1.9 | 2.7 | -0.42 |
gallstone disease (gsd) | 2.3 | 0.2 | 10.5 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.8 | 1.3 | -0.63 |
Generalized anxiety disorder | 1.7 | 0.2 | 7.5 |
Glioblastoma | 0.1 | -0.1 | |
Gout | 0.2 | 0.2 | |
Graves' disease | 0.4 | 1.1 | -1.75 |
Gulf War Syndrome | 0.4 | 0.7 | -0.75 |
Halitosis | 0.3 | 0.1 | 2 |
Hashimoto's thyroiditis | 2.4 | 1 | 1.4 |
Heart Failure | 1.7 | 1.3 | 0.31 |
hemorrhagic stroke | 0.1 | 0.1 | |
Hidradenitis Suppurativa | 0.3 | 0.1 | 2 |
High Histamine/low DAO | 0.5 | 0.5 | |
hypercholesterolemia (High Cholesterol) | 0.3 | 0.3 | |
hyperglycemia | 0.6 | 0.7 | -0.17 |
hypersomnia | 0.4 | -0.4 | |
hypertension (High Blood Pressure | 2 | 1.8 | 0.11 |
Hypothyroidism | 0.5 | -0.5 | |
Hypoxia | 0.3 | 0.3 | |
IgA nephropathy (IgAN) | 0.4 | 2.3 | -4.75 |
Inflammatory Bowel Disease | 2.7 | 4.7 | -0.74 |
Insomnia | 1 | 1.2 | -0.2 |
Intelligence | 1 | 0.3 | 2.33 |
Intracranial aneurysms | 0.7 | 0.7 | |
Irritable Bowel Syndrome | 3.1 | 1.2 | 1.58 |
ischemic stroke | 1.1 | 0.8 | 0.38 |
Liver Cirrhosis | 2.7 | 0.8 | 2.38 |
Long COVID | 2.9 | 2.7 | 0.07 |
Low bone mineral density | 0.6 | -0.6 | |
Lung Cancer | 0.2 | 0.6 | -2 |
Lymphoma | 0.2 | 0.2 | |
Mast Cell Issues / mastitis | 0.2 | 0.2 | |
ME/CFS with IBS | 0.2 | 1.7 | -7.5 |
ME/CFS without IBS | 0.9 | 0.5 | 0.8 |
Menopause | 0.1 | 0.4 | -3 |
Metabolic Syndrome | 2.8 | 2.4 | 0.17 |
Mood Disorders | 3.1 | 2.5 | 0.24 |
multiple chemical sensitivity [MCS] | 0.1 | 0.4 | -3 |
Multiple Sclerosis | 0.9 | 3 | -2.33 |
Multiple system atrophy (MSA) | 0.1 | 0.4 | -3 |
myasthenia gravis | 0.3 | 0.2 | 0.5 |
neuropathic pain | 0.7 | -0.7 | |
Neuropathy (all types) | 0.4 | 0.5 | -0.25 |
neuropsychiatric disorders (PANDAS, PANS) | 0.3 | 0.3 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 1.9 | 2 | -0.05 |
NonCeliac Gluten Sensitivity | 0.6 | 0.2 | 2 |
Obesity | 3.7 | 3 | 0.23 |
obsessive-compulsive disorder | 3 | 2.4 | 0.25 |
Osteoarthritis | 2.3 | 0.3 | 6.67 |
Osteoporosis | 0.7 | 0.7 | 0 |
Parkinson's Disease | 3.4 | 4 | -0.18 |
Polycystic ovary syndrome | 3.1 | 0.8 | 2.88 |
Postural orthostatic tachycardia syndrome | 0.1 | 0.1 | |
Premenstrual dysphoric disorder | 0.4 | 0.1 | 3 |
primary biliary cholangitis | 0.1 | 0.5 | -4 |
Primary sclerosing cholangitis | 0.6 | 2.3 | -2.83 |
Psoriasis | 1.5 | 1.3 | 0.15 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 2.5 | 2 | 0.25 |
Rosacea | 0.6 | 0.2 | 2 |
Schizophrenia | 1.8 | 1.2 | 0.5 |
scoliosis | 0.5 | 0.1 | 4 |
sensorineural hearing loss | 0.3 | 0.3 | |
Sjögren syndrome | 1.2 | 1.4 | -0.17 |
Sleep Apnea | 0.5 | 0.9 | -0.8 |
Slow gastric motility / Gastroparesis | 0.6 | 0.6 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.6 | 0.6 | |
Stress / posttraumatic stress disorder | 1 | 0.6 | 0.67 |
Systemic Lupus Erythematosus | 2.1 | 0.8 | 1.63 |
Tic Disorder | 0.7 | -0.7 | |
Tourette syndrome | 0.2 | -0.2 | |
Type 1 Diabetes | 1.6 | 0.7 | 1.29 |
Type 2 Diabetes | 3.4 | 2.7 | 0.26 |
Ulcerative colitis | 2.2 | 2.7 | -0.23 |
Unhealthy Ageing | 2.2 | 0.8 | 1.75 |
Vitiligo | 1 | 0.3 | 2.33 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]